Lixte Biotechnology Holdings Inc. (LIXT)
NASDAQ · Healthcare
Lixte Biotechnology Holdings Inc. annual/quarterly shareholder equity history from 2010 to 2015. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Lixte Biotechnology Holdings Inc. shareholder equity for the quarter ending December 31, 2015 were 312,333, a 32.20% increase year-over-year.
- Lixte Biotechnology Holdings Inc. shareholder equity for 2015 were 312,333, a 32.20% increase from 2013.
- Lixte Biotechnology Holdings Inc. shareholder equity for 2013 were 236,266, a 84.16% decrease from 2012.
- Lixte Biotechnology Holdings Inc. shareholder equity for 2012 were 1.5M, a 1787.93% increase from 2011.
- Lixte Biotechnology Holdings Inc. shareholder equity for 2011 were 79,021.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Lixte Biotechnology Holdings Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2015 | $0 |
| 2013 | $0 |
| 2012 | $1 |
| 2011 | $0 |
| 2010 | $2 |
| Lixte Biotechnology Holdings Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2015-12-31 | $0 |
| 2013-12-31 | $0 |
| 2012-12-31 | $1 |
| 2011-12-31 | $0 |
| 2010-12-31 | $2 |
Lixte Biotechnology Holdings Inc. Shareholder Equity — FAQ
Lixte Biotechnology Holdings Inc. (LIXT) shareholder equity over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LIXT's shareholder equity history?
The chart and table above show Lixte Biotechnology Holdings Inc.'s shareholder equity by year and by quarter, including the growth rate.